Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Discover which cards provide rewards without annual fees. Enjoy benefits while keeping your expenses low.
26,068 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
McDonald’s unveils its most aggressive value menu yet, with $3 items and a $4 breakfast bundle, signaling a shift in ...
Sandisk has become a hot topic for investors watching big moves in AI storage. This guide breaks down what a stock sp...
A surprising signal from Nvidia's CEO has AMD investors buzzing. This article breaks down what Jensen Huang's comment...
A fresh study shows a sizable share of U.S. investors retreat from markets during downturns, costing them years of po...
Lucid has dazzled with tech and range, but deep cash burn and production headwinds spark serious questions. Here’s a ...
Major retailers report this week to reveal whether consumer demand is stabilizing and margins are restoring. Here’s w...
Carvana’s pivot from pure online disruption to owning physical dealerships is surprising. This piece breaks down why ...
Berkshire Hathaway is sitting on an enormous cash reserve. Far from a weakness, that cash pile gives the company dry ...
Tuesday brought a notable rally in Honeywell shares as the company outlined a stand-alone path for Quantinuum. This a...
Bark is shaping its path in a competitive pet market. This guide breaks down what to expect in bark (bark) 2026 earni...
A hush-filled dinner in Edinburgh raised questions about royal finances and security. This article breaks down what t...